Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,193 | 106,121 | 186,980 | 240,387 | 187,843 |
| Marketable Securities | 88,172 | 78,660 | 3,918 | 2,451 | 3,003 |
| Other current assets | 8,320 | 10,295 | 13,526 | 5,832 | 5,796 |
| TOTAL | $167,685 | $195,076 | $204,424 | $248,670 | $196,642 |
| Non-Current Assets | |||||
| PPE Net | 5,781 | 6,018 | 6,180 | 6,272 | 6,955 |
| Investments And Advances | 0 | 0 | 15,110 | 492 | 0 |
| Other Non-Current Assets | 9,057 | 9,376 | 9,655 | 7,634 | 8,279 |
| TOTAL | $14,838 | $15,394 | $30,945 | $14,398 | $15,234 |
| Total Assets | $182,523 | $210,470 | $235,369 | $263,068 | $211,876 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,762 | 3,755 | 3,015 | 2,601 | 1,593 |
| Accrued Expenses | 12,824 | 19,239 | 25,394 | 22,760 | 19,060 |
| TOTAL | $31,653 | $41,356 | $38,957 | $34,780 | $30,098 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 13,133 | 15,067 | 7,641 | 6,637 | 6,812 |
| Other Non-Current Liabilities | 10,435 | 10,985 | 11,420 | 9,853 | 10,031 |
| TOTAL | $13,889 | $16,228 | $11,681 | $11,277 | $12,894 |
| Total Liabilities | $45,542 | $57,584 | $50,638 | $46,057 | $42,992 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,712 | 1,708 | 1,708 | 1,705 | 1,704 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -358,611 | -338,687 | -303,072 | -265,358 | -232,232 |
| Other shareholders' equity | 50 | 204 | 452 | -250 | -251 |
| TOTAL | $136,981 | $152,886 | $184,731 | $217,011 | $168,884 |
| Total Liabilities And Equity | $182,523 | $210,470 | $235,369 | $263,068 | $211,876 |